lirentelimab (AK002) - Allakos
Cinqair (reslizumab) - Merck (MSD), UCB, Teva
Nucala (mepolizumab) - GSK
Fasenra (benralizumab) - AstraZeneca
http://www.ncbi.nlm.nih.gov/pubmed/35983569
 
Aug 21, 2022
 
Prev Next